Last reviewed · How we verify
G1T48
At a glance
| Generic name | G1T48 |
|---|---|
| Also known as | Rintodestrant |
| Sponsor | G1 Therapeutics, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- G1T48 CI brief — competitive landscape report
- G1T48 updates RSS · CI watch RSS
- G1 Therapeutics, Inc. portfolio CI